• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

    160.82 -4.47 (-2.70%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 192,043
    Open 164.35
    Bid (Size) 160.18 (100)
    Ask (Size) 161.28 (2,400)
    Prev. Close 165.29
    Today's Range 156.71 - 165.29
    52wk Range 49.00 - 169.75
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs
    Via Investor Brand Network
    News headline image
    Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
    From Belite Bio, Inc
    Via GlobeNewswire

    Performance

    YTD
    +148.3%
    +148.3%
    1 Month
    +4.4%
    +4.4%
    3 Month
    +120.3%
    +120.3%
    6 Month
    +178.7%
    +178.7%
    1 Year
    +159.5%
    +159.5%

    More News

    Read More
    News headline image
    Why Belite Bio Stock Soared on Monday ↗
    Via The Motley Fool
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Outlook For Belite Bio ↗
    Via Benzinga
    News headline image
    Belite Bio's Earnings Outlook ↗
    Via Benzinga
    News headline image
    Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th
    From Virtual Investor Conferences; Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Participate in the 2025 Maxim Growth Summit
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    3 Lesser-Known Healthcare Names With Major Upside in Store ↗
    Via MarketBeat
    News headline image
    Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Participate in Three Upcoming Investor Conferences
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
    Via Benzinga

    Frequently Asked Questions

    Is Belite Bio, Inc - American Depositary Shares publicly traded?
    Yes, Belite Bio, Inc - American Depositary Shares is publicly traded.
    What exchange does Belite Bio, Inc - American Depositary Shares trade on?
    Belite Bio, Inc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Belite Bio, Inc - American Depositary Shares?
    The ticker symbol for Belite Bio, Inc - American Depositary Shares is BLTE on the Nasdaq Stock Market
    What is the current price of Belite Bio, Inc - American Depositary Shares?
    The current price of Belite Bio, Inc - American Depositary Shares is 160.82
    When was Belite Bio, Inc - American Depositary Shares last traded?
    The last trade of Belite Bio, Inc - American Depositary Shares was at 12/30/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.